Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze MD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MD investment potential.

What is MD stock price today?

Get real-time MD stock price, historical data, and price charts on Financhill. Track MD performance with our advanced analysis tools.

Is MD a good investment?

Evaluate MD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

To buy MD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MD?

View detailed market capitalization data and company valuation metrics for MD on our comprehensive analysis page.

What is the P/E ratio of MD?

Use our fundamental analysis tools to view MD P/E ratio and compare valuation metrics with industry peers.

What are MD earnings?

View MD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Pediatrix Medical Group, Inc. 10K Form

Buy

MD
Pediatrix Medical Group, Inc.

Last Price:

$22.28

Seasonality Move:

-0.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02	10Q	MD/Pediatrix Medical Group, Inc. Quarterly
2023-08-03	10Q	MD/Pediatrix Medical Group, Inc. Quarterly
2023-05-02	10Q	MD/Pediatrix Medical Group, Inc. Quarterly
2022-11-03	10Q	MD/Pediatrix Medical Group, Inc. Quarterly
2022-08-04	10Q	MD/Pediatrix Medical Group, Inc. Quarterly
2022-04-28	10Q	MD/Pediatrix Medical Group, Inc. Quarterly

Receive MD News And Ratings

See the #1 stock for the next 7 days that we like better than MD

MD Financial Statistics

Sales & Book Value

Annual Sales:	$2B
Cash Flow:	$131.9M
Price / Cash Flow:	6.97
Annual Sales:	$10.38
Price / Book:	2.15

Profitability

EPS (TTM):	1.89430
Net Income (TTM):	$162.2M
Gross Margin:	$422.1M
Return on Equity:	20.22%
Return on Assets:	7.71%

Pediatrix Medical Group, Inc. Earnings Forecast

Key Pediatrix Medical Group, Inc. Financial Ratios

The Gross Profit Margin over the past 31 years for MD is 20.97%.
The Selling, General & Administrative Expenses for MD have been equal to 11.85% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Net Earning history of MD is -4.92% of Total Revenues.
Per Share Earnings over the last 31 years have been positive in 20 years.

Pediatrix Medical Group, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Health Care Providers & Services
Sector:	Health Care
Current Symbol:	MD
CUSIP:	58502B
Website:	pediatrix.com

Debt

Debt-to-Equity Ratio:	0.72
Current Ratio:	1.83
Quick Ratio:	1.77

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	10.19

MD Technical Analysis vs Fundamental Analysis

Buy

Pediatrix Medical Group, Inc. (MD) is a Buy

Is Pediatrix Medical Group, Inc. a Buy or a Sell?

Pediatrix Medical Group, Inc. stock is rated a Buy

The current Pediatrix Medical Group, Inc. [MD] share price is $22.29. The Score for MD is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.